Marc Stapley
Chief Executive Officer at Veracyte Inc.
Sits on 2 boards. Last updated September 28, 2026
Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: Glaukos Corporation, 3 years.
Glaukos Corporation
Director
Veracyte Inc.
Director · Chief Executive Officer
Chief executive roles
Veracyte Inc.
· Chief Executive Officer
Dates unknown
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 4, 2026 | Veracyte Inc. | Option exercise | +138,051 | $36.60 | $5,052,667 |
| Jun 4, 2026 | Veracyte Inc. | Open-market sale | −138,051 | $50.12 | $6,919,116 |
| Jun 2, 2026 | Veracyte Inc. | Shares withheld for tax | −9,012 | $47.80 | $430,774 |
| May 28, 2026 | Glaukos Corporation | Grant or award | +1,878 | — | — |
| Mar 6, 2026 | Veracyte Inc. | Grant or award | +92,099 | — | — |
| Mar 4, 2026 | Veracyte Inc. | Open-market sale | −19,244 | $35.56 | $684,317 |
| Mar 4, 2026 | Veracyte Inc. | Open-market sale | −26,279 | $36.28 | $953,402 |
| Mar 2, 2026 | Veracyte Inc. | Shares withheld for tax | −19,455 | $36.01 | $700,575 |
| Feb 26, 2026 | Veracyte Inc. | Grant or award | +139,074 | — | — |
| Feb 26, 2026 | Veracyte Inc. | Shares withheld for tax | −35,841 | $38.75 | $1,388,839 |
| Jan 22, 2026 | Glaukos Corporation | Option exercise | +15,000 | $24.69 | $370,350 |
| Jan 22, 2026 | Glaukos Corporation | Open-market sale | −3,812 | $126.07 | $480,579 |
| Jan 22, 2026 | Glaukos Corporation | Open-market sale | −3,892 | $126.96 | $494,128 |
| Jan 22, 2026 | Glaukos Corporation | Open-market sale | −1,671 | $127.92 | $213,754 |
| Jan 22, 2026 | Glaukos Corporation | Open-market sale | −4,325 | $129.11 | $558,401 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.